Mountain West AETC

University of Washington

Harborview Medical Center
Mail Stop: 359932, 325 Ninth Avenue
Seattle, WA 98104
United States

Phone
(206) 543-2704

Regional Scope

The Mountain West AETC serves Alaska, Colorado, Idaho, Montana, Oregon, North and South Dakota, Utah, Washington, and Wyoming through its central office and local partners.

Contact

For HIV training, technical assistance, and/or capacity building assistance anywhere in the Mountain West  AETC region, contact [email protected].  

Principal Investigator
Program Director
Multimedia Specialist
Dental Director
Program Evaluator
Senior Computing Specialist
Regional Program Manager
Telehealth Manager
Program Support Specialist
Medical Program Director
Practice Transformation Program Coordinator
Washington State Training Coordinator
Corrections Program Director
Central and Eastern Washington Coordinator
MWAETC HIV ECHO Director/Trainer

Resources: 73

Title Publish Date Sort ascending Review Date
Regional Champions: Building on Principles of Ending the HIV Epidemic
The ABCs of Creating a Welcoming Clinic for Older Adults with HIV
Guideline Update: Statins for Primary Prevention of Cardiovascular Disease for Persons with HIV
HIV Pre-exposure Prophylaxis (PrEP) Medication Monitoring
ART in Renal Failure
Sepsis Imposters in Patients with HIV
Changes to Federal Regulations for Opioid Treatment Programs
Osteoporosis and HIV: Optimal Evaluation and Management to Prevent Fractures
Alcohol and Tobacco Use Among People with HIV
HHS Perinatal Guidelines Update
CROI 2024 Report Back: Treatment Updates
CROI 2024 Update: Co-Occurring Conditions
Practical Approaches to Polypharmacy
CROI Update: Prevention
Introducing NASTAD's Updated PrEP, PEP, and other HIV Prevention Strategies: Billing and Coding Guide
HIV and the Treatment of Depression II: Antidepressant Selection Part 1 and Part 2
Sexual History Taking
HIV PrEP: Future of PrEP
HIV & The Treatment of Depression
HIV Pre-Exposure Prophylaxis (PrEP) Expansion of Pharmacy-Delivered PrEP
Vaccine Update: COVID-19 and RSV
Fentanyl Updates
Immune Reconstitution Syndrome, 2023-Part 2
Screening and Treatment of HPV Lesions to Reduce Anal Cancer: ANCHOR Results and Implications
Addressing the Increased Risk of Lung Cancer in People with HIV
Updates to Testing and Prophylaxis for Infants with HIV Exposure
Risk of HIV Transmission with Low Levels of Viremia
Clinical Reference Tools for Sexually Transmitted Infections (STI) - Oregon
Management of HCV and HIV Coinfection
HIV Drug Resistance Testing Basics
Certification Resources for Health Care Professionals
Recent Trials of Second-Line ART: Lessons Learned & Applications to Clinical Practice
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit
Cardiovascular Risks of Antiretroviral Therapy
Pneumocystis Pneumonia: Prevention & Treatment
HIV Medication Chart Pad
Expedited Partner Therapy (EPT) Fact Sheet for Providers
ASCVD Risk Prediction to Guide Initial Statin Therapy for People with HIV
PrEP for PWID: Challenges and Opportunities
Fentanyl: A Hidden Epidemic
Pneumocystis Pneumonia: Part 1
Expedited Partner Therapy in 2022: Updated Guidance and Practical Realities
Treatment for STIs: A Guide for Medical Providers
PrEP for HIV Prevention: The 4-1-1 on 2-1-1
Unhealthy Alcohol Use Among Persons with HIV: A Modifiable Barrier to Optimal Management of HIV and its Comorbidities
“Microdosing” Buprenorphine Inductions
PrEP for Prevention of HIV in the U.S., 2021 Update
ART Update: New Guidelines & Medications
Fentanyl and Other High Potency Synthetic Opioids
Using HIV-ASSIST to Guide ART Decision-Making
Dapivirine Ring for HIV PrEP
2021 STI Treatment Guidelines Update
Cryptococcosis in People with HIV: Updated Guidelines on Prevention & Treatment
Fall Risk Evaluation & Management
Integrating Behavioral Health into Primary HIV Care — Covering the Bases
“IM” Thinking About Using Long Acting Injectables
Treating Hepatitis C Among People who Use Drugs
Operationalizing Use of Long-Acting Injectable ART
Clinically Relevant Drug Interactions with Direct Acting Antivirals (DAAs)
Medications for Methamphetamine Use Disorder
Hepatitis C Treatment Update
What will PrEP Implementation Look Like Post-COVID?
Diabetes Medications for Type 2 Diabetes with Focus on HIV: Parts 1 & 2
Pain Management in Individuals with Substance Use Disorders
Primary Care Considerations for Patients Using Methamphetamines
Understanding Frailty
Telemedicine and Opioid Use Disorder (OUD) Part 2: Clinical Tips
Hepatitis B Immunity in HIV: Case Vignette
Does this Patient Need PEP?
Telemedicine and Opioid Use Disorder: Regulatory Changes and Evidence
Telemedicine for People with HIV
HIV Non-Occupational Post-Exposure Prophylaxis (nPEP) and Processes of Patient Care
Implementing Telemedicine Webinar Series
Day Title
02/19 Addiction Medicine Webinar: A Model for Diagnosis & Management of Hepatitis C in Rural Areas (Online)
Wednesday, February 19, 2025 - 3:00pm EST to Wednesday, February 19, 2025 - 4:00pm EST
Event type: Webinars
03/19 Addiction Medicine Webinar: Addressing SUD, Homelessness in Primary and Low Barrier Care Settings (Online)
Wednesday, March 19, 2025 - 3:00pm EDT to Wednesday, March 19, 2025 - 4:00pm EDT
Event type: Webinars
06/18 Addiction Medicine Webinar: Substance Use and HIV (Online)
Wednesday, June 18, 2025 - 3:00pm EDT to Wednesday, June 18, 2025 - 4:00pm EDT
Event type: Webinars